AbbVie Inc. News Headlines

ABBV 
$48.55
*  
0.43
 negative 
0.89%
Get ABBV Alerts
*Delayed - data as of Apr. 17, 2014 
Exchange: NYSE
Industry: Health Care
Community Rating:
 
 
Symbol List Views
FlashQuotes InfoQuotes
Stock Details
Summary Quote Real-Time Quote After Hours Quote Pre-market Quote Historical Quote Option Chain
CHARTS
Basic Chart Interactive Chart
COMPANY NEWS
Company Headlines Press Releases Market Stream
STOCK ANALYSIS
Analyst Research Guru Analysis Stock Report Competitors Stock Consultant Stock Comparison
FUNDAMENTALS
Call Transcripts Annual Report Income Statement Revenue/EPS SEC Filings Short Interest Dividend History
HOLDINGS
Ownership Summary Institutional Holdings Insiders
(SEC Form 4)
 Save stocks for next time
Viewing
Filtered By
Ordered By

MARKET SNAPSHOT: Long View On Stocks Is Best During Weak Earnings Season
4/20/2014 6:01:00 AM - Dow Jones Business News

Glaxo Looking into Misconduct Charges - Analyst Blog
4/17/2014 6:35:01 PM - Zacks.com

Has A Streamlined FDA Raised The Value Of Drug Stocks?
4/17/2014 5:33:00 PM - Investor's Business Daily

Roche Meets Sales Estimates in Q1 - Analyst Blog
4/17/2014 4:00:01 PM - Zacks.com

AbbVie Candidate in Pivotal Study - Analyst Blog
4/17/2014 12:32:01 PM - Zacks.com

Ready For A Rebound? Gilead's $1000 Pill
4/17/2014 7:38:00 AM - Seeking Alpha

Glaxo's Tanzeum Approved in the U.S. - Analyst Blog
4/16/2014 6:33:01 PM - Zacks.com

Abbott Labs Tops Earnings, Misses Sales Est - Analyst Blog
4/16/2014 12:41:01 PM - Zacks.com

ITOT, QCOM, MCD, ABBV: Large Outflows Detected at ETF
4/16/2014 10:48:59 AM - BNK Invest

Abbott Laboratories Q1 Adj. Profit Beats View, Affirms 2014 Outlook
4/16/2014 9:26:00 AM - RTT News

Abbott Labs Profit Falls 31%
4/16/2014 8:44:00 AM - Dow Jones Business News

DVAX Moves On, GSK Gets FDA Nod, HART-Warming, ZGNX Gains On Favorable Ruling
4/16/2014 12:15:00 AM - RTT News

Bristol-Myers Seeks Approval for HIV Combo Drug - Analyst Blog
4/15/2014 6:30:01 PM - Zacks.com

Repros Completes Enrollment for Androxal Study - Analyst Blog
4/15/2014 6:15:01 PM - Zacks.com

Will Abbott Labs (ABT) Disappoint This Quarter? - Analyst Blog
4/15/2014 11:30:01 AM - Zacks.com

AbbVie Begins Phase III Trial Of Veliparib For NSCLC Patients
4/15/2014 8:26:00 AM - RTT News

Hard-to-Cure Patients May Benefit from Merck's HCV Drug - Analyst Blog
4/14/2014 5:10:01 PM - Zacks.com

Positive Data on AbbVie's HCV Program - Analyst Blog
4/14/2014 4:50:01 PM - Zacks.com

Will Johnson & Johnson (JNJ) Miss This Earnings Season? - Analyst Blog
4/14/2014 10:00:01 AM - Zacks.com

AbbVie To Present TURQUOISE-II Study Results At ILC
4/12/2014 1:42:00 AM - RTT News

Abbott Labs Progresses with Absorb - Analyst Blog
4/11/2014 5:40:01 PM - Zacks.com

Encouraging Data from Bristol-Myers - Analyst Blog
4/11/2014 11:30:01 AM - Zacks.com

AbbVie To Present Results From SAPPHIRE-I Study At International Liver Congress
4/11/2014 1:16:00 AM - RTT News

Merck Up on Encouraging HCV Data - Analyst Blog
4/10/2014 4:30:01 PM - Zacks.com

AbbVie Inc. (ABBV) Ex-Dividend Date Scheduled for April 11, 2014
4/10/2014 9:00:01 AM - NASDAQ.com News